Mesoblast Limited (NASDAQ:MESO) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a note issued to investors on Friday.

Other equities analysts have also issued research reports about the company. CIBC began coverage on Mesoblast Limited in a research note on Thursday, August 31st. They set an “outperform” rating and a $16.00 price objective on the stock. Maxim Group set a $14.00 price objective on Mesoblast Limited and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Zacks Investment Research upgraded Mesoblast Limited from a “sell” rating to a “hold” rating in a research note on Saturday, June 24th. Cantor Fitzgerald reiterated a “buy” rating and issued a $20.00 price target on shares of Mesoblast Limited in a research note on Wednesday, August 30th. Finally, BidaskClub lowered Mesoblast Limited from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $13.64.

Shares of Mesoblast Limited (NASDAQ:MESO) opened at 5.50 on Friday. The firm has a 50-day moving average price of $6.55 and a 200-day moving average price of $8.22. The company’s market capitalization is $467.19 million. Mesoblast Limited has a 12 month low of $4.01 and a 12 month high of $12.50.

COPYRIGHT VIOLATION NOTICE: “ValuEngine Downgrades Mesoblast Limited (MESO) to Sell” was first posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at

An institutional investor recently raised its position in Mesoblast Limited stock. Princeton Capital Management Inc. lifted its position in shares of Mesoblast Limited (NASDAQ:MESO) by 15.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 155,700 shares of the company’s stock after acquiring an additional 20,945 shares during the quarter. Princeton Capital Management Inc. owned approximately 0.20% of Mesoblast Limited worth $1,398,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 2.95% of the company’s stock.

Mesoblast Limited Company Profile

Analyst Recommendations for Mesoblast Limited (NASDAQ:MESO)

Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with's FREE daily email newsletter.